Clinical Trials on Osteosarcoma, Advanced in China

Total 1711 results

Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Osteosarcoma, Advanced

China
Beijing Immunochina Medical Science & Technology...
Guangdong Provincial People's Hospital

Not yet recruiting

IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma

Recurrent Osteosarcoma | Refractory Osteosarcoma

China
Peking University People's Hospital

Recruiting

Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

Osteosarcoma of Pelvis

China
Yuxi Su

Completed

3D Printed Personalized Extendable Prosthesis

Osteosarcoma in Children

China
Peking University People's Hospital
Peking University Shougang Hospital

Completed

Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study

Pulmonary Disease | Osteosarcoma Metastatic | Survival | Resectable Sarcoma

China
Zhejiang University

Recruiting

IMC001 for Clinical Research on Advanced Digestive System Malignancies

Advanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic Cancer

China
Peking Union Medical College Hospital

Not yet recruiting

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Liver Transplant; Complications | Recurrent Osteosarcoma | Hepatocarcinoma | High-Risk Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

A Study of CS23546 in Subjects With Advanced Tumors

Advanced Tumors

China
Biotheus Inc.

Recruiting

A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours

Advanced Tumor

China
Shenyang Pharmaceutical University

Unknown

Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients

Advanced Cancer

China
Shanghai East Hospital
Bio4T2 LLC

Active, not recruiting

A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai East Hospital
Bio4T2 LLC

Recruiting

Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors

Advanced Solid Tumor

China
Peking University People's Hospital
Jiangsu HengRui Medicine Co., Ltd.; OrigiMed

Completed

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS (CSSG-02)

Osteosarcoma

China
Lee's Pharmaceutical Limited

Recruiting

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Osteosarcoma

China
Jiangsu HengRui Medicine Co., Ltd.
Hunan Cancer Hospital

Completed

Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects

Advanced Cancer

China
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Treatment of Carrying TP53 Harmful Mutations

Advanced Cancer

China
Sunshine Lake Pharma Co., Ltd.

Completed

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of HRS2543 in Patients With Advanced Tumors

Advanced Tumors

China
Dragonboat Biopharmaceutical Company Limited

Unknown

Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors

Advanced Tumors

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors (HS:Hansoh;)

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nanjing Medical University

Completed

A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics (ALTN)

Advanced Cancer

China
Xizang Haisco Pharmaceutical Co., Ltd

Recruiting

A Study for HSK39775 in Participants With Solid Tumors

Advanced Solid Tumors

China
Tianjin ConjuStar Biologics Co., Ltd.

Recruiting

Study SC-101 in Subjects With Advanced Malignancies

Advanced Solid Tumor

China
China-Japan Friendship Hospital

Recruiting

Safety and Efficacy of Radiotherapy Combined With Immunotherapy for Advanced Malignant Tumors.

Advanced Solid Tumor

China
Sichuan Honghe Biotechnology Co., Ltd.

Recruiting

Phase 1 Trial of KH617

Advanced Solid Tumors

China
Betta Pharmaceuticals Co., Ltd.

Recruiting

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-21668

Advanced Solid Tumor

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors

Advanced Malignancies

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

A Food Effect Study of SPH5030 Tablets.

Advanced Solid Tumor

China
Bristol-Myers Squibb

Completed

Study of Relatlimab in Combination With Nivolumab in Chinese Participants (RELATIVITY-111)

Advanced Solid Tumors

China
Innovent Biologics (Suzhou) Co. Ltd.

Withdrawn

IBI397 or Combination Therapies in Patients With Advanced Malignancies

Advanced Malignancies

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets

Advanced Solid Tumors

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of AL2846 on Tolerance and Pharmacokinetics

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics

Advanced Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A SHR-1210 BE Study on Healthy Subjects

Advanced Tumors

China
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor

Advanced Tumors

China
Bristol-Myers Squibb

Completed

A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Sinotecean on Tolerance and Pharmacokinetics

Advanced Cancer

China
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; Qilu Hospital... and other collaborators

Recruiting

Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma (Li2CO3)

Osteosarcoma

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors

Advanced Tumors

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQB3824 in Subjects With Advanced Cancer

Advanced Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Study of IBI323 in Patients With Advanced Malignancies

Advanced Malignancies

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Safety and Efficacy of IBI322 in Chinese Subjects With Advanced Malignant Tumors

Advanced Malignancies

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

Advanced Solid Tumor

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Study of IBI318 in Participants With Advanced Malignancies

Advanced Malignancy

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies

Advanced Malignancies

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of TQB3455 Tablets in Subjects With Advanced Malignancies

Advanced Malignancies

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Study of Anlotinib in Subjects With Advanced Malignancy

Advanced Malignancy

China
Shanghai East Hospital

Unknown

Clinical Study of Granulocyte Infusion for Advanced Cancer

Advanced Cancer

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer

Advanced Solid Cancer

China
Haihe Biopharma Co., Ltd.

Unknown

A Phase I Study of SCC244

Advanced Solid Tumor

China

Clinical Trials on Osteosarcoma, Advanced in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations